Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Ophthalmic migraine, Pyrexia, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Cognitive fog; Ocular migraine; Dizziness; Injection site discomfort; Burning sensation behind the eyes; pruritus at injection site; erythema at injection site; Fever 101+; Chills; Arthralgia; Fatigue; Headache; Myalgia; Nausea; This spontaneous case was reported by a health care professional and describes the occurrence of COGNITIVE DISORDER (Cognitive fog), OPHTHALMIC MIGRAINE (Ocular migraine), DIZZINESS (Dizziness), INJECTION SITE DISCOMFORT (Injection site discomfort) and EYE IRRITATION (Burning sensation behind the eyes) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Drug allergy, Food allergy, Dust allergy and Seasonal allergy. Concomitant products included METOPROLOL SUCCINATE (TOPROL XL) and HYDROCHLOROTHIAZIDE for Hypertension, FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Multiple allergies.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COGNITIVE DISORDER (Cognitive fog), OPHTHALMIC MIGRAINE (Ocular migraine), DIZZINESS (Dizziness), INJECTION SITE DISCOMFORT (Injection site discomfort), EYE IRRITATION (Burning sensation behind the eyes), VACCINATION SITE PRURITUS (pruritus at injection site), VACCINATION SITE ERYTHEMA (erythema at injection site), PYREXIA (Fever 101+), CHILLS (Chills), ARTHRALGIA (Arthralgia), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Myalgia) and NAUSEA (Nausea). At the time of the report, COGNITIVE DISORDER (Cognitive fog), OPHTHALMIC MIGRAINE (Ocular migraine), DIZZINESS (Dizziness), INJECTION SITE DISCOMFORT (Injection site discomfort), EYE IRRITATION (Burning sensation behind the eyes), VACCINATION SITE PRURITUS (pruritus at injection site), VACCINATION SITE ERYTHEMA (erythema at injection site), PYREXIA (Fever 101+), CHILLS (Chills), ARTHRALGIA (Arthralgia), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Myalgia) and NAUSEA (Nausea) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient reporting a delayed local reaction on days 12 and 13 after dose 1 of the Moderna COVID vaccine administration. Erythema and pruritus at injection site. Both began after patient stopped receiving the v-safe daily check-ins.   This case was linked to MOD-2021-075991 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: follow up was received on 19 Apr 2021, reporter information was updated, patient details were updated(age, height and weight), medical history was updated (hypertension and allergy), vaccine information was updated (start date, batch no., dosage text, route, anatomical site), concomitant drugs were updated.